查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1825316

栓塞保护装置市场：2025-2030 年预测

Embolic Protection Devices Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

栓塞防护装置市场预计将从 2025 年的 711,396,000 美元成长到 2030 年的 1,045,758,000 美元，复合年增长率为 8.01%。

栓塞保护装置 (EPD) 市场是介入性心臟病学和血管外科领域的一个细分市场，致力于预防高风险手术中的併发症。这些装置旨在收集隐静脉移植物 (SVG) 和其他血管结构内的血液和管腔碎片，最大限度地减少远端栓塞，并降低围手术期心肌梗塞和主要不良心血管事件 (MACE) 的风险。

技术平台及临床应用

栓塞防护装置的作用是在经皮心臟和血管介入治疗过程中捕获并清除脱落的物质，防止碎片堵塞下游小动脉。该技术提供实证保护，防止斑块颗粒迁移到远端血管床，从而提高手术安全性和患者预后。

其主要临床应用包括颈动脉置入术和隐静脉移植介入治疗，这两种介入治疗均具有极高的栓塞风险。该装置也正在评估其在肾动脉和其他血管区域的应用，但在这些应用中的临床有效性仍需进一步的对照试验检验。

其根本价值提案是透过机械阻断可能导致下游血管併发症的碎片来预防不良临床后果。这种保护机制已在成熟的应用中显示出显着的临床益处，尤其是在高风险患者群体中。

市场成长的关键驱动力

心血管和神经血管疾病盛行率的上升是市场的主要驱动力，从而对介入手术中的防护技术产生了持续的需求。心血管疾病负担的不断加重，使得受益于栓塞保护的手术和非手术治疗方法的应用日益增加。

经导管主动脉瓣置换术(TAVR) 的推广正在创造更大的市场需求，因为这种复杂的介入手术本身就具有栓塞风险，而这些风险可以透过保护装置来降低。随着 TAVR 系统被更广泛的患者群体所采用，对全面栓塞防护策略的需求也日益增长。

提高消费者和医生对栓塞防护设备的认识，将有助于改善手术规划和风险缓解策略，进而促进市场成长。教育活动和临床证据的传播将增进人们对该设备优势和合适使用情境的理解。

微创手术的需求将推动市场扩张，因为这些手术通常涉及较高的栓塞风险，需要采取保护措施。器械设计、输送能力和疗效的技术改进将进一步推动市场成长，扩大其适用范围并改善手术效果。

政府机构、非政府组织和教育机构正在进行有关心血管和神经血管疾病及其治疗方案的宣传活动，从而透过增加治疗量和风险意识间接支持市场成长。

地理市场分布

北美是心血管疾病高发生率地区，且医疗基础设施先进，支援复杂的介入手术，因此是主要的细分市场。肥胖、生活方式和饮食习惯等区域性因素加剧了心血管疾病的负担，从而对防护技术产生了持续的需求。

北美拥有众多产业参与企业，透过技术创新、临床研究和产品供应支持市场发展。该地区的法规环境和报销框架促进了医疗器材的普及和市场渗透。

亚太地区拥有巨大的成长潜力，主要原因是人口老化加剧，更容易罹患心血管和神经病变。都市化趋势、生活方式的改变以及肥胖和高血压等风险因素的日益普遍，为市场扩张提供了机会。

中国等国家的政府支持和医疗改革透过改善先进医疗技术和介入程序的获取，为市场发展创造了有利条件。

市场限制与技术挑战

高产品故障率是市场成长的一大限制因素，为广泛应用带来了临床和经济方面的障碍。在关键手术过程中，设备故障会危及病人安全，并降低医生对技术的信心。

产品召回和品质问题导致设备可靠性和性能存在不确定性，进一步阻碍了市场扩张。医疗设备业高度重视安全性和有效性，要求产品性能始终如一，以维持市场认可。

栓塞保护装置的报销政策不足，为医疗服务提供者和患者带来了经济障碍，限制了其应用。限制性的保险覆盖政策可能会将其使用限制在某些高风险情况下，从而限制整体市场的成长潜力。

竞争格局

该市场由知名医疗设备公司组成，包括雅培实验室、波士顿科学公司、美敦力公司、戈尔医疗、康德乐健康、创新心血管解决方案、Emboline 公司、NIPRO、丝绸之路医疗和 Keystone Heart（启明医疗），他们透过产品创新、临床证据生成和战略市场定位展开竞争。

战略产业影响

对于医疗设备业的专业人士来说，栓塞保护器材市场代表着介入性心臟病学进展与病人安全提升交会的机会。成功的关键在于平衡技术创新与临床证据发展，并兼顾成本效益考量，因为这些因素会影响不同医疗体系的采用决策。

本报告的主要优点

  • 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解主要企业所采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力进行策略决策，并在动态环境中开闢新的业务流和收益。
  • 适合广泛的使用者：对于新兴企业、研究机构、顾问、中小企业和大型企业来说都是有益且具有成本效益的。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（尤其是财务状况和关键发展）

目录

第一章执行摘要

第二章市场概述

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

5. 栓塞保护装置市场（按类型）

  • 介绍
  • 远端闭塞系统
  • 近端闭塞系统
  • 远端过滤系统

6. 栓塞保护装置市场（依程序）

  • 介绍
  • 冠状动脉手术
  • 週边动脉手术
  • 颈动脉手术
  • 肾动脉手术
  • 其他的

7. 栓塞保护装置市场（依最终用户）

  • 介绍
  • 医院
  • 门诊手术中心
  • 专科诊所

8. 栓塞保护装置市场（按地区）

  • 介绍
  • 北美洲
    • 按类型
    • 透过手术
    • 按最终用户
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按类型
    • 透过手术
    • 按最终用户
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按类型
    • 透过手术
    • 按最终用户
    • 按国家
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 按类型
    • 透过手术
    • 按最终用户
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 按类型
    • 透过手术
    • 按最终用户
    • 按国家
      • 中国
      • 日本
      • 印度
      • 韩国
      • 台湾
      • 其他的

第九章：竞争格局及分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章：公司简介

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic Plc.
  • Silk Road Medical, Inc.
  • Emboline Inc.
  • Nipro Corporation
  • Edwards Lifesciences

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061610441

The Embolic Protection Devices Market is expected to grow from USD 711.396 million in 2025 to USD 1,045.758 million in 2030, at a CAGR of 8.01%.

The embolic protection devices (EPDs) market represents a specialized segment within interventional cardiology and vascular surgery, focused on preventing periprocedural complications during high-risk procedures. These devices are designed to collect blood and luminal debris within saphenous vein grafts (SVG) and other vascular structures, minimizing distant embolization and reducing the risk of periprocedural myocardial infarction and major adverse cardiovascular events (MACE).

Technology Foundation and Clinical Applications

Embolic protection devices function by capturing and removing dislodged material during percutaneous cardiac and vascular interventions, preventing debris from causing blockages in smaller downstream arteries. The technology provides evidence-based protection against plaque particle migration to distal vascular beds, improving procedural safety and patient outcomes.

Primary clinical applications include carotid artery stenting procedures and saphenous vein graft interventions, where the risk of embolic events is particularly elevated. The devices are also being evaluated for use in renal arteries and other vascular territories, though clinical effectiveness in these applications requires further validation through controlled studies.

The fundamental value proposition centers on preventing unfavorable clinical outcomes by mechanically intercepting debris that would otherwise cause downstream vascular complications. This protective mechanism has demonstrated significant clinical benefit in established applications, particularly in high-risk patient populations.

Primary Market Growth Drivers

The rising prevalence of cardiovascular and neurovascular disorders represents the most significant market driver, creating sustained demand for protective technologies during interventional procedures. The growing burden of cardiovascular disease necessitates increased utilization of surgical and non-surgical treatment modalities that benefit from embolic protection.

The expansion of Trans-catheter Aortic Valve Replacement (TAVR) procedures creates additional market demand, as these complex interventions carry inherent embolic risks that protection devices can mitigate. The growing adoption of TAVR systems across broader patient populations amplifies the need for comprehensive embolic protection strategies.

Increasing consumer and physician awareness of embolic protection devices contributes to market growth through improved procedural planning and risk mitigation strategies. Educational initiatives and clinical evidence dissemination enhance understanding of device benefits and appropriate utilization scenarios.

The demand for less invasive procedures drives market expansion, as minimally invasive interventions often carry higher embolic risks that require protective measures. Technical improvements in device design, deliverability, and effectiveness further support market growth by expanding the range of suitable applications and improving procedural outcomes.

Government agencies, non-governmental organizations, and educational institutions are conducting awareness campaigns regarding cardiovascular and neurovascular diseases and their treatment options, indirectly supporting market growth through increased procedural volumes and risk awareness.

Geographic Market Distribution

North America represents a leading market segment, driven by high cardiovascular disease prevalence and advanced healthcare infrastructure supporting complex interventional procedures. Regional factors including obesity, lifestyle patterns, and dietary habits contribute to cardiovascular disease burden, creating sustained demand for protective technologies.

The strong presence of key industry participants in North America supports market development through innovation, clinical research, and product availability. The region's regulatory environment and reimbursement frameworks facilitate device adoption and market penetration.

The Asia Pacific region presents significant growth potential, supported by rapidly aging populations susceptible to cardiovascular and neurological disorders. Urbanization trends, lifestyle changes, and increasing prevalence of risk factors including obesity and hypertension contribute to market expansion opportunities.

Government support and healthcare reforms in countries such as China create favorable conditions for market development through improved access to advanced medical technologies and interventional procedures.

Market Constraints and Technical Challenges

High product failure rates represent a significant constraint on market growth, creating clinical and economic barriers to widespread adoption. Device failures during critical procedures can compromise patient safety and reduce physician confidence in the technology.

Product recalls and quality issues further impede market expansion by creating uncertainty regarding device reliability and performance. The medical device industry's emphasis on safety and efficacy requires consistent product performance to maintain market acceptance.

Inadequate reimbursement policies for embolic protection devices limit adoption by creating economic barriers for healthcare providers and patients. Limited coverage policies may restrict utilization to specific high-risk scenarios, constraining overall market growth potential.

Competitive Landscape

The market features established medical device companies including Abbott Laboratories, Boston Scientific Inc., Medtronic Plc., Gore Medical, Cardinal Health, Innovative Cardiovascular Solutions, Emboline Inc., NIPRO, Silk Road Medical, and Keystone Heart (Venus MedTech). These companies compete through product innovation, clinical evidence generation, and strategic market positioning.

Strategic Industry Implications

For medical device industry professionals, the embolic protection devices market represents opportunities at the intersection of interventional cardiology advancement and patient safety improvement. Success requires balancing technological innovation with clinical evidence development and addressing cost-effectiveness considerations that influence adoption decisions across diverse healthcare systems.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Embolic Protection Devices Market Segmentation:

By Type

  • Distal Occlusion Systems
  • Proximal Occlusion Systems
  • Distal Filter Systems

By Procedure

  • Coronary Artery Procedures
  • Peripheral Artery Procedures
  • Carotid Artery Procedures
  • Renal Artery Procedures
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. EMBOLIC PROTECTION DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Distal Occlusion Systems
  • 5.3. Proximal Occlusion Systems
  • 5.4. Distal Filter Systems

6. EMBOLIC PROTECTION DEVICES MARKET BY PROCEDURE

  • 6.1. Introduction
  • 6.2. Coronary Artery Procedures
  • 6.3. Peripheral Artery Procedures
  • 6.4. Carotid Artery Procedures
  • 6.5. Renal Artery Procedures
  • 6.6. Others

7. EMBOLIC PROTECTION DEVICES MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Specialty Clinics

8. EMBOLIC PROTECTION DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Procedure
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Procedure
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Procedure
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Procedure
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Procedure
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abbott Laboratories
  • 10.2. Boston Scientific Corporation
  • 10.3. Medtronic Plc.
  • 10.4. Silk Road Medical, Inc.
  • 10.5. Emboline Inc.
  • 10.6. Nipro Corporation
  • 10.7. Edwards Lifesciences

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations